ÂÜÀòÂÒÂ×

Holly Micolochick Steuer is a seasoned scientist with extensive experience in the biopharmaceutical industry. Currently serving as a Scientist at Arbutus Biopharma Corporation since June 2016, Holly focuses on identifying new therapeutics for chronic Hepatitis B infection. Previously, experience includes roles as Associate Scientist I at Gilead Sciences, where contributions involved studying immune responses in HBV patients, and as a Scientist at Pharmasset, Inc., developing small molecule therapeutics for Hepatitis C and B. Additional roles span research positions at Verto Institute, Purdue Pharma, Sanofi Pasteur, and Penn State University, reinforcing expertise in immunotherapy, cell biology, and vaccine development. Holly holds a Bachelor of Science degree from King's College and has completed graduate credits in Molecular Biology at Lehigh University.